From the Center
AllSides Media Bias Rating: Center
Food and Drug Administration (FDA) Commissioner Marty Makary said he has no plans to change current policy to restrict access to the abortion pill mifepristone, despite a steady pressure campaign from abortion opponents.
Speaking at the Semafor World Economy Summit on Thursday, Makary said he would reconsider if there is new data that would suggest a safety issue.
Check for Bias
The AI-powered AllSides Bias Checker instantly reveals the bias of a news article. Tap the button to use.
Related Coverage
AllSides Picks
Headline Roundup
Massachusetts Expected to Allow Abortions at Any Stage
July 31st, 2026
Recommended Reading
Courts, Crackdowns, and Civil Right Violations: 6 New Stories You Probably Havenβt Seen
Malayna J. Bizier
August 5th, 2026
News
Tracking Trumpβs Campaign Promises
AllSides Staff
July 24th, 2026
Red Blue Translator